EPI-Q is a health economics and outcomes research company dedicated to providing novel research, strategic direction, and communications solutions. EPI-Q uncovers and communicates the true value of healthcare innovation by generating, analyzing and publishing data that demonstrate outcomes and establish value throughout a product’s lifecycle. For more than 27 years, EPI-Q has assisted Fortune 100 biopharmaceutical and medical device firms demonstrate the clinical and economic value of medical therapies and technologies – enhancing the quality of clinical practice and patient care. EPI-Q drives the development of evidence and value propositions to support product commercialization, facilitate market access, and optimize pricing and reimbursement. EPI-Q’s resident multidisciplinary experts consist of seasoned individuals with experience as front line healthcare practitioners, methodologists, health economists, and policy makers. This combination assists clients by creating custom solutions that inform the decision-making of patients, providers, payers, and regulators based on credible real-world evidence. With an international network spanning the payer, provider, policy and academic communities, EPI-Q can tailor and execute your global strategies, plans and research in the most effective, efficient and customized way.